[ad_1]
Shorten the URL
BioNTech CEO Prof. Dr. Uğur Şahin said he was confident that the Covid-19 vaccine would ‘crush the head of the virus and end the epidemic that has taken over the world’. Şahin stated that the vaccine will be prepared in two doses three weeks apart and will provide at least one year of protection.
Explaining that he received successful results from the first clinical trials in coronavirus vaccine studies, the professor, CEO of the Germany-based company BioNTech. Dr. Uğur Şahin said that the vaccine ‘will end the corona virus epidemic’. Şahin stated that he is confident that the Covid-19 vaccine they developed will ‘crush the head of the virus and end the epidemic that gripped the world in 2020’.
According to the Turkish BBC report, Şahin stated that when they got the news with Özlem Türeci, the company’s chief medical consultant and his wife, they sat down for tea and chatted a bit and said: “It was a very good feeling. chill out”.
In their press release on Monday, Pfizer and BioNTech noted that in phase 3 of the vaccination trials, 90 percent of the volunteers prevented the disease from developing, and this rate was better than expected. However, the question of whether the vaccine is effective in asymptomatic infections has not been answered, as the results of the trial have not yet been fully disclosed.
Saying that he is optimistic about this, Şahin said “If the question is whether we can stop the pandemic with this vaccine, then my answer is yes, because protection against even symptomatic infections will have a huge impact.” said. Stating that they are not sure whether the vaccine will trigger a strong enough response in the immune system until the results of the test studies are announced, Şahin said. “Now we know that the vaccine will defeat this virus.” I speak.
Şahin, 55, said he believed the vaccine would also prevent transmission of the virus, although it has not been officially tested due to the results obtained regarding the effect of the vaccine they developed. Stating that the vaccine attacks the corona virus “in more ways than one,” Şahin said. “It prevents Covid-19 from entering our cells. But even if the virus has somehow entered, it allows the cells to hit the head of the virus and kill it. We have very well trained the immune system to perform these two defensive actions. We now know that the virus cannot defend itself against these mechanisms. “ I speak.
Stating that some important questions about the vaccine’s effectiveness can be answered in the coming weeks and months, Şahin noted that answering the question of whether it can stop asymptomatic infections can take up to a year.
While in conventional vaccines the genetic information is obtained from the virus and is reproduced in the human cell, in the method known as mRNA, only the genetic code of the virus is sufficient, which is why it is affirmed that the production process of the virus vaccine is shortened by three months. Sahin says the vaccine development process takes just 10 months instead of years, thanks to Pfizer’s expertise in producing vaccines for large markets and the quick response of health officials who set drug regulations.
Stating that the answer to the question of whether the vaccine will provide different levels of protection to different age groups will be clear within three weeks, Şahin said that it is not yet clear whether it will have a different effect on different ethnic groups. Şahin noted that the vaccine will be given in two doses to the arm, three weeks apart, providing protection for at least a year.
Claiming that they got the results of the vaccine trials on Sunday night, Şahin said: “ There was a huge load on our heads. ” “Drug research should never be a political tool … Hiding information would be unethical. What matters to us is that we are developing vaccines and not doing politics.”
BioNTech shares rose rapidly after the results were announced on Monday. The value of the company approached $ 30 billion. However, Şahin said that money is just ‘numbers on pieces of paper’ for now:
“There will come a time when we will think about what to do next with our money. Often times, people who create something new want to create something new again. We will have to decide what this is, whether it will be a foundation or a special project.”
[ad_2]
